Tapping Specialty Market Potential Tops SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
5. ODAC Recommends Approval for Herceptin Biosimilar
Trastuzumab is indicated as an adjuvant therapy for HER2-positive breast cancer, along with metastatic breast and gastric cancers.
4. Cancer Mortality High in Rural America
Rural areas have a higher rate of death for lung, colorectal, prostate, and cervical cancers.
3. Patients Say Biosimilars, Biologics Should Require Same Type, Level of Testing
New report provides insight into patient awareness and attitudes towards biosimilars.
2. Specialty Drugs Provide Financial Challenges for Employers
Integrating medical and pharmacy benefits may better inform employer management of specialty drugs.
1. Is it Time to Take Another Look at Retail at Specialty Pharmacy?
The concept of specialty at retail has the potential to unlock vast financial, contracted volume, and patient continuum of care opportunities attached to pharmaceutical products currently dispensed in specialty pharmacies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
